Stock Research for HALO

HALO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

HALO Stock Chart & Research Data

The HALO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the HALO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


HALO Due diligence Resources & Stock Charts

The HALO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View HALO Detailed Price Forecast - CNN Money CNN View HALO Detailed Summary - Google Finance
Yahoo View HALO Detailed Summary - Yahoo! Finance Zacks View HALO Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View HALO Trends & Analysis - Trade-Ideas Barrons View HALO Major Holders - Barrons
NASDAQ View HALO Call Transcripts - NASDAQ Seeking View HALO Breaking News & Analysis - Seeking Alpha
Spotlight View HALO Annual Report - CompanySpotlight.com OTC Report View HALO OTC Short Report - OTCShortReport.com
TradeKing View HALO Fundamentals - TradeKing Charts View HALO SEC Filings - Bar Chart
WSJ View Historical Prices for HALO - The WSJ Morningstar View Performance/Total Return for HALO - Morningstar
MarketWatch View the Analyst Estimates for HALO - MarketWatch CNBC View the Earnings History for HALO - CNBC
StockMarketWatch View the HALO Earnings - StockMarketWatch MacroAxis View HALO Buy or Sell Recommendations - MacroAxis
Bullish View the HALO Bullish Patterns - American Bulls Short Pains View HALO Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View HALO Stock Mentions - StockTwits PennyStocks View HALO Stock Mentions - PennyStockTweets
Twitter View HALO Stock Mentions - Twitter Invest Hub View HALO Investment Forum News - Investor Hub
Yahoo View HALO Stock Mentions - Yahoo! Message Board Seeking Alpha View HALO Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for HALO - SECform4.com Insider Cow View Insider Transactions for HALO - Insider Cow
CNBC View HALO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for HALO - OTC Markets
Yahoo View Insider Transactions for HALO - Yahoo! Finance NASDAQ View Institutional Holdings for HALO - NASDAQ


Stock Charts

FinViz View HALO Stock Insight & Charts - FinViz.com StockCharts View HALO Investment Charts - StockCharts.com
BarChart View HALO Stock Overview & Charts - BarChart Trading View View HALO User Generated Charts - Trading View


Latest Financial News for HALO

Free Technical Research on ImmunoGen and Three More Biotech Equities
Posted on Friday June 22, 2018

On Thursday, June 21, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Eight out of nine sectors ended Thursday's trading session in bearish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Biotechnology equities this morning: Grifols S.A. (NASDAQ: GRFS), Halozyme Therapeutics Inc. (NASDAQ: HALO), ImmunoCellular Therapeutics Ltd (NYSE AMER: IMUC), and ImmunoGen Inc. (NASDAQ: IMGN).


Report: Exploring Fundamental Drivers Behind Virtu Financial, Littelfuse, Gogo, Brookfield Asset Management, Protalix BioTherapeutics, and Halozyme Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
Posted on Wednesday June 13, 2018

NEW YORK, June 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Virtu ...


Halozyme President And Chief Executive Officer, Dr. Helen Torley Named EY Entrepreneur Of The Year 2018 San Diego
Posted on Monday June 11, 2018

SAN DIEGO, June 11, 2018 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced Dr. Helen Torley, president and chief executive officer, was awarded the honor of Entrepreneur Of The Year® 2018 San Diego in the category of Operational Excellence by a panel of independent judges. The EY Entrepreneur Of The Year program recognizes the endeavors of exceptional entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. "Under Helen's leadership, Halozyme has not only made significant progress growing the ENHANZE technology franchise and studying the potential for our investigational oncology drug, but also in strengthening our culture and commitment to excellence.


See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.
Posted on Friday June 08, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.


Enter a stock symbol to view the stock details.